Board & Management

Board of Directors

Name & Position Experience

Mr. Bryan Dulhunty

Director, Chairman, Company Secretary

Bryan brings a wealth of life science experience to the position having been involved in the industry for the past 20 years. Bryan provides a range of consulting services to the life science industry. Bryan has served as a director of a number of listed ASX and non-listed life science companies, including holding the positions of Executive Chairman and Managing Director of Viralytics Ltd from 2005 to 2012. Bryan is a Chartered Accountant and holds an Economics Degree from Sydney University.

Mr. Andrew Kroger

BEc. LLB, Non-Executive Director

Mr. Kroger has had a career in stockbroking, law and general management including two years running Forsayth Group in 1990 which was Australia’s ninth largest gold producer at that time. Mr Kroger is the owner of Process Wastewater Technologies LLC, a company with its major business being in wastewater in the United States. Mr. Kroger has a Bachelor of Economics and a Bachelor of Laws from Monash University. Mr. Kroger was appointed to the Cryosite Limited board in November 2011.

Mrs Nicola Swift

BA (Mod) Legal Science, MA, CFA, GAICD, Non-Executive Director

Mrs Swift has an extensive background in the international investment management and securities industry as a research director, portfolio manager and equity analyst. She has over 16 years of experience gained in London, Sydney and Boston with global institutional investors such as Alliance Capital, AMP, and John Hancock’s, International Investment Associates. Her career has been spent rigorously analysing and investing in a range of both listed and private companies at varying stages in their development. Mrs Swift is a Chartered Financial Analyst, a graduate of the Australian Institute of Corporate Directors and holds an Honours Law degree and a Masters of Arts from Trinity College Dublin. She is also a Director of Ascham Foundation Ltd and Ascham School Ltd. Mrs Swift was appointed to the Board on 3 November 2016. Mrs Swift is the Chair of the Audit and Risk committee.

Management Team

Name & Position Experience

Mr Mark Byrne

BEc, CA, MBA, GAIDC, CSA, Interim CEO and CFO

Mr Byrne is a senior leader with over 25 years extensive global experience and a record of success in a number of multi-national companies with different ownership structures (listed, privately owned and private equity). Mr Byrne has extensive leadership experience having being member of boards & senior management throughout the majority of his career. Mr Byrne has been involved in a number of different industries including medical devices, technology, telecommunications and direct marketing. Mr Byrne is a Chartered Accountant, a graduate of the Australian Institute of Corporate Directors, Chartered Secretary and hold a Master of Business Administration from Macquarie University, Sydney. Mr Byrne joined Cryosite in June 2016 as CFO and in June 2017 was appointed Interim CEO.

Mr Rory Carroll

CSCP, Head of Clinical Trials, Director of Operations

A strategic Manager who has lead Healthcare Operations throughout Asia and Australia, with a strong reputation for innovation and performance through partnership, developing high quality teams, and driving customer success. Rory has gained extensive experience working in senior management positions in pharmaceutical and medical technology companies including Siemens Healthcare, Novartis Pharmaceuticals, and Alcon Laboratories. Rory has held advisory council positions for NEHTA’s Healthcare Supply Chain Reform, and GS1 Healthcare Leadership Group for Australia and NZ. Mr Carroll joined Cryosite in November 2016 as a consultant and become an employee in January 2017.

Shane Johnston

PhD, Cryosite Quality Assurance and Regulatory Manager

Dr. Johnston has extensive experience in Quality Management and Regulatory Affairs obtained over the last 25 years within the pharmaceutical and biotechnology industries. Dr Johnston holds a PhD (field of medicine) from the University of Queensland. Dr Johnston has extensive experience in GMP, GCP, GWP and GLP and a comprehensive knowledge of the regulatory issues involving the manufacture and distribution of therapeutic products. Dr Johnston joined Cryosite in June 2014.

Latest Share Price

Latest Announcements

Sign Up for Investor Alerts

Subscribe to the investor alerts to recieve the latest announcement updates and weekly reports.

Sign Up